课题基金 / 基金详情

MULTIPLE DOSES OF SUBCUTANEOUS RHUIL-10 IN PATIENTS WITH ACTIVE CROHN'S DISEASE

MULTIPLE DOSES OF SUBCUTANEOUS RHUIL-10 IN PATIENTS WITH ACTIVE CROHN'S DISEASE
活动性克罗恩病患者皮下注射 RHUIL-10 的多次剂量
批准号：
6113882
负责人：
KIM L ISAACS
金额：
$1.58万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6113882
关键词：
Crohn's disease clinical research dosage drug administration routes drug screening /evaluation drug tolerance gastrointestinal disorder chemotherapy human subject human therapy evaluation interleukin 10 recombinant proteins

项目摘要

项目成果

KIM L ISAACS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of the study is to study the safety and tolerance of retreatment with multiple doses of subcutaneous SCH 52000 in patients with chronic active Crohn's disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: MULTI-SITE TRIAL OF AZATHIOPRINE DOSING IN CROHN'S DISEASE
MULTI-SITE TRIAL OF AZATHIOPRINE DOSING IN CROHN'S DISEASE
AZATHIOPRINE LOADING TO DECREASE RESPONSE TIME IN CROHN'S DISEASE
TAK 603/A 165646 IN PATIENTS W/ CROHNS DISEASE
海外基金